Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis

被引：140

作者：

Cholewinski, Grzegorz ^{[1
]}

Dzierzbicka, Krystyna ^{[1
]}

Kolodziejczyk, Aleksander M. ^{[1
]}

机构：

[1] Gdansk Univ Technol, Dept Organ Chem, PL-80233 Gdansk, Poland

来源：

PHARMACOLOGICAL REPORTS | 2011年 / 63卷 / 02期

关键词：

acridine/acridone analogs; synthesis; biological activity; anticancer activity; RESISTANT CELL-LINES; 9-SUBSTITUTED ACRIDINE-DERIVATIVES; TELOMERE TARGETING AGENTS; ACRIDONE DERIVATIVES; CYTOTOXIC ACTIVITY; ANTICANCER AGENTS; TUMOR-CELLS; DNA-BINDING; TRIAZOLOACRIDONE C-1305; PRECLINICAL EVALUATION;

D O I：

10.1016/S1734-1140(11)70499-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Acridine derivatives constitute a class of compounds that are being intensively studied as potential anticancer drugs. Acridines are well-known for their high cytotoxic activity; however, their clinical application is limited or even excluded because of side effects. Numerous synthetic methods are focused on the preparation of target acridine skeletons or modifications of naturally occurring compounds, such as acridone alkaloids, that exhibit promising anticancer activities. They have been examined in vitro and in vivo to test their importance for cancer treatment and to establish the mechanism of action at both the molecular and cellular level, which is necessary for the optimization of their properties so that they are suitable in chemotherapy. In this article, we review natural and synthetic acridine/acridone analogs, their application as anticancer drugs and methods for their preparation.

引用

页码：305 / 336

页数：32

共 105 条

[21] Acridine and acridone derivatives, anticancer properties and synthetic methods: Where are we now? [J].

Belmont, Philippe ;

Bosson, Johann ;

Godet, Thomas ;

Tiano, Martin .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (02) :139-169

[22] Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series [J].

Bongui, JB ;

Elomri, A ;

Cahard, D ;

Tillequin, F ;

Pfeiffer, B ;

Pierré, A ;

Seguin, E .

CHEMICAL & PHARMACEUTICAL BULLETIN, 2005, 53 (12) :1540-1546

[23]

Borowski E, 2005, ACTA BIOCHIM POL, V52, P609

[24] Reactivity of pyrido[4,3,2-kl]acridines:: Regioselective formation of 6-substituted derivatives [J].

Bouffier, L ;

Demeunynck, M ;

Milet, A ;

Dumy, P .

JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (23) :8144-8147

[25] Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine.: Synthesis, antitumor activity, and DNA binding [J].

Bouffier, Laurent ;

Baldeyrou, Brigitte ;

Hildebrand, Marie-Paule ;

Lansiaux, Amelie ;

David-Cordonnier, Marie-Helene ;

Carrez, Daniele ;

Croisy, Alain ;

Renaudet, Olivier ;

Dumy, Pascal ;

Demeunynck, Martine .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (22) :7520-7530

[26] Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2 [J].

Boumendjel, Ahcene ;

Macalou, Sira ;

Ahmed-Belkacem, Abdelhakim ;

Blanc, Madeleine ;

Di Pietro, Attilio .

BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (08) :2892-2897

[27]

BOUSQUET PF, 1995, CANCER RES, V55, P1176

[28] Structural basis of DNA quadruplex recognition by an acridine drug [J].

Campbell, Nancy H. ;

Parkinson, Gary N. ;

Reszka, Anthony P. ;

Neidle, Stephen .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (21) :6722-+

[29]

Capps D.B., 1984, European Patent E.P., Patent No. 0145226

[30]

Capps DB, 1984, Eur Patent, Patent No. 138302

← 1 2 3 4 5 6 7 8 9 10 →